LPL Financial
CSTL icon

LPL Financial’s Castle Biosciences CSTL Stock Holding History

LPL Financial’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$238K Sell
9,700
-1,177
-11% -$38.5K ﹤0.01% 5365
2025
Q4 		$423K Buy
10,877
+1,480
+16% +$47.7K ﹤0.01% 4868
2025
Q3 		$214K Buy
+9,397
New +$191K ﹤0.01% 5299
2025
Q1 		– Sell
-23,043
Closed -$614K – 5392
2024
Q4 		$614K Sell
23,043
-3,421
-13% -$104K ﹤0.01% 3913
2024
Q3 		$755K Buy
+26,464
New +$674K ﹤0.01% 3657

Other funds holding CSTL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $3.72B AUM 162.29% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LPL Financial's CSTL Position: Q1 2026 in Review

LPL Financial reduced its Castle Biosciences (CSTL) stake by 11% in Q1 2026, selling an estimated $38.5K and leaving 9,700 shares worth $238K. The position accounts for ﹤0.01% of the portfolio, ranked #5365.

LPL Financial first reported a position in CSTL in Q3 2024 and has held it in 5 quarters since. The position peaked at $755K in Q3 2024. 186 funds tracked by Wall St. Rank hold CSTL as of Q1 2026.

  • LPL Financial held 9,700 shares of Castle Biosciences worth $238K as of Q1 2026.
  • LPL Financial sold 1,177 Castle Biosciences shares in Q1 2026, an estimated $38.5K.
  • Castle Biosciences made up ﹤0.01% of LPL Financial's portfolio in Q1 2026, its #5365 holding.
  • LPL Financial first reported a position in Castle Biosciences in Q3 2024 and has held it in 5 quarters since.
  • LPL Financial's Castle Biosciences position peaked at $755K in Q3 2024.
  • 186 funds tracked by Wall St. Rank held Castle Biosciences as of Q1 2026.

Based on LPL Financial's 13F filing for Q1 2026, filed 6 May 2026.